Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SNS 301

Next Previous
Search
Drug Profile

SNS 301

Alternative Names: HAAH vaccine; PAN-301; PAN-301-1; SNS-301

Latest Information Update: 09 Jul 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Panacea Pharmaceuticals
  • Developer Sensei Biotherapeutics
  • Class Antineoplastics; Bacteriophages; Cancer vaccines; Immunotherapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Head and neck cancer; Myelodysplastic syndromes; Prostate cancer

Most Recent Events

  • 02 Jun 2023 Updated efficacy and adverse events data from a phase I/II trial in Squamous cell cancer presented at the 59th Annual Meeting of the American Society of Clinical Oncology (ASCO-2023)
  • 12 Aug 2021 Sensei Biotherapeutics terminates a phase-I/II clinical trials in Squamous cell cancer (Combination therapy, Inoperable/Unresectable, Late-stage disease, Metastatic disease, Recurrent) in USA (Intradermal), due to sponsor's decision (NCT04034225)
  • 28 Jun 2021 Discontinued - Clinical-Phase-Unknown for Head and neck cancer (Intradermal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top